VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 126 filers reported holding VIRIDIAN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,456,516 | +49.3% | 2,963,267 | +131.6% | 1.76% | +24.6% |
| Q2 2023 | $30,439,353 | -2.7% | 1,279,502 | +4.0% | 1.41% | +9.6% |
| Q1 2023 | $31,297,789 | -39.5% | 1,230,259 | -30.5% | 1.28% | -40.8% |
| Q4 2022 | $51,735,408 | +28.0% | 1,771,154 | -10.1% | 2.17% | +17.3% |
| Q3 2022 | $40,411,000 | +198.5% | 1,970,290 | +68.4% | 1.85% | +108.0% |
| Q2 2022 | $13,540,000 | -37.4% | 1,170,290 | 0.0% | 0.89% | -35.9% |
| Q1 2022 | $21,639,000 | -18.1% | 1,170,290 | -12.4% | 1.39% | -25.6% |
| Q4 2021 | $26,426,000 | – | 1,336,690 | – | 1.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 3,082,622 | $47,287,421 | 4.98% |
| COMMODORE CAPITAL LP | 2,200,000 | $33,748,000 | 3.94% |
| Paradigm Biocapital Advisors LP | 3,681,747 | $56,477,999 | 3.83% |
| Vivo Capital, LLC | 1,678,207 | $25,743,695 | 2.82% |
| Fairmount Funds Management LLC | 1,369,623 | $21,010,017 | 2.53% |
| Octagon Capital Advisors LP | 1,067,143 | $16,369,974 | 2.52% |
| ACUTA CAPITAL PARTNERS, LLC | 224,339 | $3,441,360 | 2.31% |
| Logos Global Management LP | 1,050,000 | $16,107,000 | 2.15% |
| Kopp Family Office, LLC | 214,290 | $3,287 | 2.08% |
| 5AM Venture Management, LLC | 410,000 | $6,289,400 | 1.81% |